Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

ClinicalTrials.gov ID: NCT07284472

Public ClinicalTrials.gov record NCT07284472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 22, 2026, 1:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants With Alzheimer's Disease Dementia

Study identification

NCT ID: NCT07284472
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Exciva GmbH; Industry
Enrollment: 300 participants

Conditions and interventions

Conditions

Agitation Associated With Alzheimer's Disease Dementia

Interventions

EXV-801 Drug
EXV-802 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 55 Years to 90 Years
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 1, 2026
Primary completion: Dec 31, 2028
Completion: Jan 31, 2029
Last update posted: Apr 16, 2026

2026 – 2029

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
Esperanza Clinical	Murrieta	California	92562	Recruiting
Josephson Wallack Munshower Neurology PC	Indianapolis	Indiana	46260	Recruiting
Precise Research Centers	Flowood	Mississippi	39232	Recruiting
Integrative Clinical Trials	Brooklyn	New York	11229	Recruiting
Manhattan Behavioral Medicine	New York	New York	10036	Recruiting
Insight Clinical Trials	Independence	Ohio	44131	Recruiting
Oregon Health & Science University	Portland	Oregon	97239	Not yet recruiting
The Memory Clinic	Bennington	Vermont	05201	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07284472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07284472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →